Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Vanessa Picceli"'
Autor:
Laís Zanlorenzi, Kamilla de Bessa Jorge, Anauá Fernanda Cavalcante, Vanessa Picceli, Thiago Alberto Dos Santos, Carolina Ferreira, Renato Nishiara, Fernanda Baracho, Thelma Larocca Skare
Publikováno v:
Anais do Congresso Brasileiro de Reumatologia 2020.
Autor:
Thelma L SKARE, Carolina FERREIRA, Fernanda Ribas BARACHO, Vanessa PICCELI, Gleyne Lopes Kujew BIAGINI, Zila Ferreira Dias Goncalves DOS SANTOS, Carlos Hespanha MARINHO JUNIOR, Renato NISIHARA
Publikováno v:
Revista Médica do Paraná. 79:1617
RESUMO - Antitopoisomerase-1 (ou Scl-70) é um autoanticorpo considerado como biomarcador da forma difusa de esclerodermia. Alguns autores o têm encontrado em pacientes com lúpus. O objetivo deste estudo foi estudar a presença do anticorpo Scl-70
Autor:
Iara J.T. Messias-Reason, Thelma Larocca Skare, Shirley Ramos da Rosa Utiyama, Flávia Raphaela Nass, Renato Nisihara, Vanessa Picceli
Publikováno v:
Lupus. 25:412-417
Background B factor (BF) from the alternative complement pathway seems to participate in the pathophysiology of systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). Objective To study the allotypic variability of BF in SLE and thei
Autor:
Cesar Maistro Guimarães, Vanessa Picceli, Iara Messias-Reason, Kárita Cláudia Freitas Lidani, Thaisa Lucas Sandri, Fabiana Antunes Andrade
Publikováno v:
Immunobiology. 221:1184
Autor:
Vanessa Picceli, Bruno Bandolin Barbosa, Thelma L. Skare, Renato Nisihara, Alvaro da Luz, Shirley Ramos da Rosa Utiyama
Publikováno v:
Clinical rheumatology. 32(7)
Recently, it has been found that some lupus patients may have anti-cyclic citrullinated peptide antibodies (anti-CCP), although the clinical significance of such finding is not well established. Systemic lupus erythematosus (SLE) patients may have jo
Autor:
Shirley Ramos da Rosa Utiyama, Renato Nisihara, Iara de Messias-Reason, Thelma Larocca Skare, Vanessa Picceli, Luiz Roberto Kotze
Publikováno v:
Europe PubMed Central
Background Organ-specific autoimmune diseases may appear in patients with systemic lupus erythematosus (SLE). Gastrointestinal symptoms are well documented in SLE and may be similar to those related to autoimmune gastrointestinal diseases. Objective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3991fbfb87d7fba9ab9908f0082eac6c
http://europepmc.org/abstract/med/24057059
http://europepmc.org/abstract/med/24057059